Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’ scientific focus is on the relationship between angiogenesis, the immune system and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
To learn more, visit www.compasstherapeutics.com
Company Details
- Employees
- 47
- Founded
- -
- Address
- 80 Guest Street,
- me****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- compasstherapeutics.com
- HQ
- Boston, MA
Compass Therapeutics Inc. Questions
Compass Therapeutics Inc.'s website is compasstherapeutics.com
Compass Therapeutics Inc.'s LinkedIn profile is https://www.linkedin.com/company/compass-therapeutics-llc
Compass Therapeutics Inc. has
47 employees.
View email and phone details for 47
employees at Compass Therapeutics Inc..
Compass Therapeutics Inc.'s industry is
Biotechnology Research
Compass Therapeutics Inc.'s top competitors are
Stellaromics Inc.,
Pledge Therapeutics,
Scismic,
Nona Biosciences,
Cugene Inc.,
Aviceda Therapeutics,
Marengo Therapeutics,
Incendia Therapeutics,
Oddity Labs,
Seaport Therapeutics.
Compass Therapeutics Inc.'s support email address is media@compasstherapeutics.com
Compass Therapeutics Inc.'s categories are Biotechnology Research
Compass Therapeutics Inc.'s founding year is 2014
